PYC Other Stockholder Equity from 2010 to 2024
| PYC Stock | 1.40 0.05 3.45% |
Other Stockholder Equity | First Reported 2005-06-30 | Previous Quarter -21.9 M | Current Value -21.9 M | Quarterly Volatility 6.8 M |
Check PYC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PYC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 51.7 K, Cost Of Revenue of 1.5 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as . PYC financial statements analysis is a perfect complement when working with PYC Therapeutics Valuation or Volatility modules.
PYC | Other Stockholder Equity |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PYC Stock Analysis
When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.